Bayesian Self‐Optimization for Telescoped Continuous Flow Synthesis
Angewandte Chemie International Edition · 16.01.2023 · 62 (3)
DOI: 10.1002/anie.202214511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 13.12.2022. Verfasst von Adam D Clayton und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Process Research and Development, Schools of Chemistry & Chemical and Process Engineering, University of Leeds, Leeds, LS2 9JT, UK. Hauptthemen laut MEDLINE: Bayes Theorem. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
The optimization of multistep chemical syntheses is critical for the rapid development of new pharmaceuticals. However, concatenating individually optimized reactions can lead to inefficient multistep syntheses, owing to chemical interdependencies between the steps. Herein, we develop an automated continuous flow platform for the simultaneous optimization of telescoped reactions. Our approach is applied to a Heck cyclization‐deprotection reaction sequence, used in the synthesis of a precursor for 1‐methyltetrahydroisoquinoline C5 functionalization. A simple method for multipoint sampling with a single online HPLC instrument was designed, enabling accurate quantification of each reaction, and an in‐depth understanding of the reaction pathways. Notably, integration of Bayesian optimization techniques identified an 81 % overall yield in just 14 h, and revealed a favorable competing pathway for formation of the desired product.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Process Research and Development, Schools of Chemistry & Chemical and Process Engineering, University of Leeds, Leeds, LS2 9JT, UK.
- IBM Research UK, Daresbury Laboratory, Daresbury, WA4 4AD, UK.
- ISEL, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
- Chemical Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
- UCB Pharma SA, All. de la Recherche 60, 1070, Anderlecht, Belgium.
- Institute of Process Research and Development, School of Mechanical Engineering, University of Leeds, Leeds, LS2 9JT, UK.
ORCID-Profile: Adam D Clayton, Edward O Pyzer-Knapp, Nikil Kapur, Thomas W Chamberlain, A John Blacker, Richard A Bourne
Förderung
- Engineering and Physical Sciences Research Council
Zitieren
APA
Clayton, A. D., Pyzer-Knapp, E. O., Purdie, M., Jones, M. F., Barthelme, A., Pavey, J., Kapur, N., Chamberlain, T. W., Blacker, A. J., & Bourne, R. A. (2023). Bayesian Self‐Optimization for Telescoped Continuous Flow Synthesis. Angewandte Chemie International Edition, 62(3). https://doi.org/10.1002/anie.202214511
Vancouver
Clayton AD, Pyzer-Knapp EO, Purdie M, Jones MF, Barthelme A, Pavey J, et al. Bayesian Self‐Optimization for Telescoped Continuous Flow Synthesis. Angewandte Chemie International Edition. 2023;62(3). doi:10.1002/anie.202214511
BibTeX
@article{Clayton2023,
author = {Clayton, Adam D and Pyzer-Knapp, Edward O and Purdie, Mark and Jones, Martin F and Barthelme, Alexandre and Pavey, John and Kapur, Nikil and Chamberlain, Thomas W and Blacker, A John and Bourne, Richard A},
title = {Bayesian Self‐Optimization for Telescoped Continuous Flow Synthesis},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {3},
doi = {10.1002/anie.202214511}
}
EUVIMED